Byamukama, Ambrose
Atukunda, Mucunguzi
Arinitwe, Elizabeth
Twinamatsiko, Brian
Mutabazi, Andrew
Ayebare, Michael
Tindimwembwa, Winston
Asiimwe, Alan
Nangendo, Joan
Okello, Emmy
Mutungi, Gerald
Kamya, Moses R.
Kabami, Jane
Charlebois, Edwin D.
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (CSA2018HS-2518)
European and Developing Countries Clinical Trials Partnership (CSA2018HS-2518)
European and Developing Countries Clinical Trials Partnership (CSA2018HS-2518)
European and Developing Countries Clinical Trials Partnership (CSA2018HS-2518)
Article History
Received: 31 July 2025
Accepted: 24 April 2026
First Online: 11 May 2026
Declarations
:
: All participants provided informed consent to take part in the study. The study was conducted in accordance with the Declaration of Helsinki and it was approved by Makerere University School of Medicine Research Ethics Committee on September 8, 2020 (approval number: 2020 − 156), the London School of Hygiene and Tropical Medicine on September 2, 2020 (approval number: 22196), and the Uganda National Council for Science and Technology on November 9, 2020 (approval number: HS979ES). Confidentiality was strictly maintained throughout the study.
: Not applicable.
: The authors declare no competing interests.